Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Helen Floersh reports a research team in China has discovered a potential new treatment for Alzheimer’s disease. In a clinical trial with mice, the team targeted myeloid cells that can cross the blood-brain barrier and develop into new immune cells to consume amyloid-beta plaques. (Fierce Biotech)

Scientists at Brigham and Women’s Hospital in Boston, Massachusetts, researching the monoclonal antibody Foralumab delivered via nasal spray, show evidence that the drug decreases lung inflammation in patients with COVID-19. (Inside Precision Medicine)

Kimberly McGhee details how the South Carolina Clinical & Translational Research Institute is developing innovative strategies to increase participation in clinical trials. (MUSC Catalyst News)

‍
‍

Our Culture

“We create a template so we can pull back the timelines and eliminate concerns around quality and risk—because everything’s already validated in the design. Then we can work faster with no risk to quality.”

   –Jamie, Trial Delivery

‍

‍‍
‍

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.

‍